<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?properties manuscript?><?origin nihpa?><?iso-abbr Nat Commun?><?submitter-system nihms?><?submitter-canonical-name Nature Publishing Group?><?submitter-canonical-id NATURE-STRUCTUR?><?submitter-userid 8068858?><?submitter-authority myNCBI?><?submitter-login nature-structure?><?submitter-name Nature Publishing Group?><?domain nihpa?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101528555</journal-id><journal-id journal-id-type="pubmed-jr-id">37539</journal-id><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-title-group><journal-title>Nature communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn></journal-meta><article-meta><article-id pub-id-type="pmcid">4425231</article-id><article-id pub-id-type="pmid">25946967</article-id><article-id pub-id-type="doi">10.1038/ncomms8068</article-id><article-id pub-id-type="manuscript">nihpa676392</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>I&#x003ba;B&#x003b2; enhances the generation of the low-affinity NF&#x003ba;B/RelA homodimer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tsui</surname><given-names>Rachel</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Kearns</surname><given-names>Jeffrey D.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="author-notes" rid="FN1">+</xref></contrib><contrib contrib-type="author"><name><surname>Lynch</surname><given-names>Candace</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="author-notes" rid="FN2">#</xref></contrib><contrib contrib-type="author"><name><surname>Vu</surname><given-names>Don</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Ngo</surname><given-names>Kim</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Basak</surname><given-names>Soumen</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="author-notes" rid="FN3">%</xref></contrib><contrib contrib-type="author"><name><surname>Ghosh</surname><given-names>Gourisankar</given-names></name><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hoffmann</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="aff" rid="A2">2</xref><xref ref-type="aff" rid="A3">3</xref><xref ref-type="aff" rid="A4">4</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Signaling Systems Laboratory, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375</aff><aff id="A2"><label>2</label>The San Diego Center for Systems Biology, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375</aff><aff id="A3"><label>3</label>Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Dr. M/C 0375, La Jolla, CA 92093-0375</aff><aff id="A4"><label>4</label>Department of Microbiology, Immunology and Molecular Genetics (MIMG), and the Institute for Quantitative and Computational Biosciences (QCB), University of California, Los Angeles, CA 90095</aff><author-notes><corresp id="cor1"><label>*</label>To whom correspondence should be addressed: Alexander Hoffmann - <email>ahoffmann@ucla.edu</email></corresp><fn id="FN1" fn-type="present-address"><label>+</label><p id="P1">Current Addresses:</p><p id="P2">Merrimack Pharmaceuticals, Cambridge, MA 02139.</p></fn><fn id="FN2" fn-type="present-address"><label>#</label><p id="P3">The Scripps Research Institute, La Jolla, CA 92037.</p></fn><fn id="FN3" fn-type="present-address"><label>%</label><p id="P4">Systems Immunology Laboratory, National Institute of Immunology. Aruna Asaf Ali Marg, New Delhi-110067, India.</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>31</day><month>3</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>07</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>07</day><month>11</month><year>2015</year></pub-date><volume>6</volume><fpage>7068</fpage><lpage>7068</lpage><!--elocation-id from pubmed: 10.1038/ncomms8068--><permissions><license xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms"><license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<ext-link ext-link-type="uri" xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</ext-link></license-p></license></permissions><abstract><p id="P5">The NF&#x003ba;B family of dimeric transcription factors regulate inflammatory and immune responses. While the dynamic control of NF&#x003ba;B dimer activity via the I&#x003ba;B-NF&#x003ba;B signaling module is well understood, there is little information on how specific dimer repertoires are generated from Rel family polypeptides. Here we report the iterative construction &#x02013; guided by <italic>in vitro</italic> and <italic>in vivo</italic> experimentation &#x02013; of a mathematical model of the Rel-NF&#x003ba;B generation module. Our study reveals that I&#x003ba;B&#x003b2; has essential functions within the Rel-NF&#x003ba;B generation module, specifically for the RelA:RelA homodimer, which controls a subset of NF&#x003ba;B target genes. Our findings revise the current dogma of the three classical, functionally-related I&#x003ba;B proteins by distinguishing between a positive &#x02018;licensing&#x02019; factor (I&#x003ba;B&#x003b2;) that contributes to determining the available NF&#x003ba;B dimer repertoire in a cell&#x02019;s steady state, and negative feedback regulators (I&#x003ba;B&#x003b1; and -&#x003b5;) that determine the duration and dynamics of the cellular response to an inflammatory stimulus.</p></abstract></article-meta></front><body><sec sec-type="intro" id="S1"><title>Introduction</title><p id="P6">The NF&#x003ba;B family of dimeric transcription factors are known to control the development, maturation, and responses of the immune system comprising diverse cell types. Resting, unstimulated cells contain a latent pool of NF&#x003ba;B dimers in the cytosol that are stoichiometrically associated with their inhibitors, the I&#x003ba;Bs (<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R2" ref-type="bibr">2</xref>). NF&#x003ba;B transcription factors are produced by homo- or hetero- dimerization from a pool of five Rel homology domain-containing proteins (RelA, RelB, cRel, p50, and p52). The I&#x003ba;B family comprises several isoforms including the classical I&#x003ba;B&#x003b1;, I&#x003ba;B&#x003b2;, I&#x003ba;B&#x003b5; proteins, and the I&#x003ba;B&#x003b3; and I&#x003ba;B&#x003b4; activities contained within the higher molecular weight I&#x003ba;Bsome (<xref rid="R3" ref-type="bibr">3</xref>). Combinatorial dimerization and I&#x003ba;B-NF&#x003ba;B interactions are hallmarks of the I&#x003ba;B-NF&#x003ba;B signaling system.</p><p id="P7">The coordinated functions of I&#x003ba;B proteins in controlling the dynamics of NF&#x003ba;B activity have been studied systematically using a combined experimental and mathematical modeling approach. Specifically, mathematical modeling recapitulates key mechanisms, such as stimulus-responsive, I&#x003ba;B kinase (IKK)-dependent degradation of I&#x003ba;Bs, release of nuclear NF&#x003ba;B DNA binding activity, as well as subsequent attenuation <italic>via</italic> the negative feedback regulators I&#x003ba;B&#x003b1;, I&#x003ba;B&#x003b5;, A20, and I&#x003ba;B&#x003b4; (<xref rid="R4" ref-type="bibr">4</xref>). Interestingly, these studies did not identify a critical function for I&#x003ba;B&#x003b2;, and I&#x003ba;B&#x003b2; -deficient mice and cells show attenuated, not increased inflammatory responses (<xref rid="R5" ref-type="bibr">5</xref>).</p><p id="P8">In contrast, little recent progress has been reported on how NF&#x003ba;B dimers are generated. Early studies led to an appreciation that the NF&#x003ba;B transcription factor family consists of up to 15 possible dimers, and that different dimers are detectable in different cell types (<xref rid="R1" ref-type="bibr">1</xref>). In fact, the NF&#x003ba;B dimer repertoire changes dramatically during cell differentiation; for example B-cell lines with early lineage markers contain primarily RelA:p50, while those with later lineage markers contain primarily cRel:p50 dimers (<xref rid="R6" ref-type="bibr">6</xref>). In murine embryonic fibroblasts (MEFs), the RelA:p50 heterodimer and the RelA:RelA homodimer have been observed and shown to be responsible for the expression of distinct target genes (<xref rid="R7" ref-type="bibr">7</xref>). Indeed, despite its much lower abundance in fibroblasts, the RelA:RelA homodimer was shown to have non-redundant functions for a subset of NF&#x003ba;B target genes, with the specificity being mediated by &#x003ba;B-site DNA sequences as well as transcriptional co-activators (<xref rid="R8" ref-type="bibr">8</xref>). However, surprisingly little is known about the mechanisms that control the formation of these distinct NF&#x003ba;B dimers that are critical for mediating gene-specific expression control. Indeed, we presently lack a quantitative understanding of the most fundamental processes of monomer synthesis and subsequent dimer formation.</p><p id="P9">Here, we have employed mathematical modeling and experimental approaches iteratively to study the mechanisms that control the fibroblast-specific NF&#x003ba;B dimer repertoire. Guided by a model based on first principles of protein&#x02013;protein interactions, and using <italic>in vitro</italic> biophysical interaction measurement, we found that we can only account for the <italic>in vivo</italic> observations of low affinity dimers when we considered additional mechanisms. Specifically, combined experimental and computational studies revealed that I&#x003ba;B&#x003b2; functions as a positive regulator within the Rel-NF&#x003ba;B dimer generation module, and is essential for the formation of RelA:RelA homodimers. In contrast, I&#x003ba;B&#x003b1; is the key regulator of the dynamics of NF&#x003ba;B activity, not only of RelA:p50 but also of RelA:RelA. We conclude that the classical I&#x003ba;Bs actually fall into two classes; whereas I&#x003ba;B&#x003b1; and -&#x003b5; primarily function within the I&#x003ba;B-NF&#x003ba;B signaling module that is responsive to inflammatory stimuli, I&#x003ba;B&#x003b2; primarily functions within the Rel-NF&#x003ba;B dimer generation module. The resulting model not only recapitulates experimental observations, but also explains the contrasting phenotypes of mice deficient for each of the classical I&#x003ba;Bs.</p></sec><sec sec-type="results" id="S2"><title>Results</title><sec id="S3"><title>NF&#x003ba;B dimerization affinities and monomer competition</title><p id="P10">To address the molecular basis for the generation of a MEF-specific repertoire of NF&#x003ba;B dimers within the so-called &#x02018;Rel-NF&#x003ba;B dimer generation module&#x02019;, we first considered the fundamental principles pertaining to the generation of homo- and hetero-dimers from the classical NF&#x003ba;B proteins p50 (50) and RelA (A), which are present in all differentiated human cells, and which show distinct gene-expression specificities (<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R8" ref-type="bibr">8</xref>). Dimer abundance may be thought of as a function of monomer synthesis (<italic>m<sub>1</sub></italic>, <italic>m<sub>2</sub></italic>) and degradation (<italic>m<sub>&#x02212;1</sub></italic>, <italic>m<sub>&#x02212;2</sub></italic>), and combinatorial dimer association (<italic>d<sub>1</sub></italic>, <italic>d<sub>2</sub></italic>, <italic>d<sub>3</sub></italic>) and dissociation (<italic>d<sub>&#x02212;1</sub></italic>, <italic>d<sub>&#x02212;2</sub></italic>, <italic>d<sub>&#x02212;3</sub></italic>) rate constants (<xref ref-type="fig" rid="F1">Figure 1A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 1, Supplementary Note 1</xref>). As RNAseq data show very similar absolute abundances of the RelA and p50 encoding mRNAs in wild-type MEFs (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1A</xref>), the synthesis rates of the protein monomers are assumed to be equal in the model. As Rel proteins are obligate dimers, monomers are incompletely folded and more rapidly degraded <italic>in vivo</italic> than when dimerized (<italic>dd<sub>&#x02212;1</sub></italic>, <italic>dd<sub>&#x02212;2</sub></italic>, <italic>dd<sub>&#x02212;3</sub></italic>) (<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>).</p><p id="P11">Dimerization affinities are key determinants of cellular homo- and hetero- dimer abundances. We simulated the abundance of RelA:RelA (A:A) and RelA:p50 (A:50) dimers as a function of those dimer affinities keeping the p50:p50 dimer affinity constant at 30 nM (<xref ref-type="fig" rid="F1">Figure 1B</xref>), 3 nM and 300 nM (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1B</xref>). Whereas p50:p50 dimerization affinity did not affect A:A or A:50 abundances over that range, the simulations do illustrate an interdependence between A:A and A:50 formation, whereby p50 competes for RelA monomers and may thus inhibit A:A generation. To test whether monomer competition occurs in cells, we compared <italic>nfkb1<sup>&#x02212;/&#x02212;</sup></italic> (which lack p50) and wild type murine embryo fibroblasts (MEFs) and found an increase in the abundance of the A:A homodimers. These data support the concept that monomer competition is physiologically relevant and tends to diminish the abundances of weaker affinity dimers (<xref ref-type="fig" rid="F1">Figure 1C&#x02013;E</xref>).</p><p id="P12">To parameterize the model, we next measured dimer affinities with biophysical techniques. Homodimer affinities were measured by analytical ultracentrifugation (AUC) using purified recombinant RelA and p50 dimerization domains (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1C</xref>). The heterodimer affinity was deduced from quantitative gel filtration experiments that provided the ratios of dimer abundances (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 1D&#x02013;F</xref>). We found remarkably disparate affinities: whereas the interactions by p50 proteins were found within the expected range (5&#x02013;40 nM), the A:A homodimer affinity was in the &#x000b5;M range (<xref ref-type="fig" rid="F2">Figure 2A</xref>). Employing these rate constants in the kinetic model resulted in the prediction that the A:A homodimers would have exceedingly low abundance (&#x0003c;4% of total RelA-containing dimers), due to a weak A:A affinity and the above-described monomer competition. However, testing this prediction experimentally, we found that A:A homodimers were readily detectable in cells amounting to about a quarter of TNF-inducible NF&#x003ba;B activities (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Thus, the mismatch between model prediction and experimental results suggested that there might be additional mechanisms controlling dimer abundance, that are not included in this version of the kinetic model.</p></sec><sec id="S4"><title>Interaction affinities between I&#x003ba;B isoforms and NF&#x003ba;B dimers</title><p id="P13">Given that I&#x003ba;Bs associate along a large dimerization interface (<xref rid="R11" ref-type="bibr">11</xref>), and NF&#x003ba;Bs interacting with I&#x003ba;Bs protect the latter from degradation (<xref rid="R12" ref-type="bibr">12</xref>&#x02013;<xref rid="R14" ref-type="bibr">14</xref>), we considered the possibility that I&#x003ba;Bs may stabilize RelA-containing NF&#x003ba;B dimers. (Classical I&#x003ba;Bs do not interact with p50:p50 (<xref rid="R15" ref-type="bibr">15</xref>).) To test this idea, we extended the mathematical model by including I&#x003ba;B synthesis (<italic>i<sub>1</sub></italic>) and degradation (<italic>i<sub>&#x02212;1</sub></italic>) and its interaction with A:A homodimers and A:50 heterodimers (<italic>di<sub>1</sub></italic>, <italic>di<sub>&#x02212;1</sub></italic>, <italic>di<sub>2</sub></italic>, <italic>di<sub>&#x02212;2</sub></italic>) (<xref ref-type="fig" rid="F3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 2, Supplementary Note 2</xref>). In the resulting model, NF&#x003ba;B dimer abundances are then also a function of I&#x003ba;B abundances and the interaction affinities between NF&#x003ba;B dimers and I&#x003ba;B proteins. These interactions are thought to be tight, (<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R17" ref-type="bibr">17</xref>) but systematic measurements using biophysical methods are hampered by the challenge of expressing and purifying full-length recombinant proteins that are not fully folded in the apo-form and have a tendency to aggregate.</p><p id="P14">To address this challenge, we developed an approach to derive <italic>in vivo</italic> I&#x003ba;B-NF&#x003ba;B affinities. The fact that I&#x003ba;B&#x003b1;, I&#x003ba;B&#x003b2;, and I&#x003ba;B&#x003b5; protein abundances in MEFs deficient in classical NF&#x003ba;B dimers (<italic>rela<sup>&#x02212;/&#x02212;</sup>crel<sup>&#x02212;/&#x02212;</sup>nfkb1<sup>&#x02212;/&#x02212;</sup></italic>) were much more reduced than their corresponding mRNA levels (<xref ref-type="fig" rid="F3">Figure 3B</xref>), indicated the degree to which the interaction with NF&#x003ba;B stabilized the half-life of the three classical I&#x003ba;Bs as established by previous reports (<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R14" ref-type="bibr">14</xref>). We reasoned that measurements of relative abundances of I&#x003ba;B proteins in mutant cells with alternate NF&#x003ba;B dimer repertoires could be used to infer <italic>in vivo</italic> I&#x003ba;B-NF&#x003ba;B dimer affinities.</p><p id="P15">To distinguish I&#x003ba;B interaction affinities for the A:50 and A:A dimers, we produced composite NF&#x003ba;B knockout MEFs (<italic>relb<sup>&#x02212;/&#x02212;</sup>nfkb2<sup>&#x02212;/&#x02212;</sup>nfkb1<sup>&#x02212;/&#x02212;</sup>crel<sup>&#x02212;/&#x02212;</sup></italic>) in which RelA is the sole NF&#x003ba;B protein family member, and RelA-deficient MEFs, which do not contain A:A homodimers but contain the partially compensating cRel:p50 heterodimer in place of A:50 (<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R18" ref-type="bibr">18</xref>) (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 2A, B</xref>). Using these cells, the experimentally determined I&#x003ba;B&#x003b1; / I&#x003ba;B&#x003b2; abundance ratios (<xref ref-type="fig" rid="F3">Figure 3C</xref>) constrained the acceptable ranges of I&#x003ba;B-NF&#x003ba;B affinities <italic>via</italic> model parameter fitting procedures (<xref ref-type="fig" rid="F4">Figure 4A</xref>). For example, in A:50-deficient cells, the I&#x003ba;B&#x003b1; abundance was reduced to 35 +/&#x02212; 8% of that in wild type cells, constraining the I&#x003ba;B&#x003b1;-A:A and I&#x003ba;B&#x003b1;-A:50 affinity to a narrow band within the two dimensional parameter space (top left panel). In contrast, I&#x003ba;B&#x003b2; abundance was hardly affected (76% +/&#x02212; 24% of the wild type cells) and provided less constraint on the acceptable affinities of I&#x003ba;B&#x003b2; -A:A and I&#x003ba;B&#x003b2; -A:50 interactions based on the particular parameter landscape (top right panel). Similarly, I&#x003ba;B&#x003b1; and I&#x003ba;B&#x003b2; abundance measurements in A:A-deficient cells provided additional constraints (bottom panels). The overlap of these acceptable ranges for each I&#x003ba;B in both NF&#x003ba;B knockout conditions determined not a single parameter set, but rather a narrower range of parameters that can account for all available experimental data.</p><p id="P16">As the NF&#x003ba;B dimer affinity and I&#x003ba;B abundance measurements are associated with experimental error, we sought to characterize the resulting uncertainty about the true I&#x003ba;B-NF&#x003ba;B affinities. To do so, we calculated a probability for each I&#x003ba;B abundance based on a two-fold variance around the mean of NF&#x003ba;B affinity measurements. Then we compared these values to the experimentally determined distributions (defined by mean and standard deviation) of I&#x003ba;B abundances. This allowed us to determine the likelihood that a given pair of I&#x003ba;B-A:A and I&#x003ba;B-A:50 affinities is true based on all available experimental data along with its associated uncertainty (<xref ref-type="fig" rid="F4">Figure 4B</xref>). This analysis allowed us to define the ranges of probable I&#x003ba;B-dimer affinities and it demonstrated that I&#x003ba;B&#x003b2; was consistently predicted to have a clear preference for A:A over A:50 (&#x0003e;100 fold). We chose seven parameter sets as representatives of the probable and improbable parameter spaces governing I&#x003ba;B&#x003b1; and I&#x003ba;B&#x003b2; interactions (<xref ref-type="fig" rid="F4">Figure 4B</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>) in order to ascertain their likelihood in further cell biological assays.</p></sec><sec id="S5"><title>Testing the model of I&#x003ba;B&#x003b2; controlling the RelA homodimer</title><p id="P17">Using the combination of probable and improbable parameter sets (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>) for I&#x003ba;B-NF&#x003ba;B dimer affinities within the experimentally determined ranges, we parameterized a mathematical model to account for the generation of distinct RelA dimers (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 3, Supplementary Note 3</xref>). We developed three predictions that depend on high I&#x003ba;B&#x003b2; preference for the A:A homodimer and tested them experimentally. First, we used the model to calculate the basal abundance of RelA protein in cells containing only RelA (<italic>relb<sup>&#x02212;/&#x02212;</sup>nfkb2<sup>&#x02212;/&#x02212;</sup>nfkb1<sup>&#x02212;/&#x02212;</sup>crel<sup>&#x02212;/&#x02212;</sup></italic>) under two regimes, probable and improbable affinity predictions (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>). We found that most probable affinity sets predicted a lower decrease (~1.5&#x02013;2 fold) in RelA protein levels than most improbable affinity sets (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Indeed, immunoblot analysis showed only a small decrease (~1.5 fold) in RelA protein (<xref ref-type="fig" rid="F5">Figure 5C</xref>).</p><p id="P18">Second, we used the model to simulate the steady state abundances of I&#x003ba;B-bound NF&#x003ba;B dimers in wild type cells; this resulted in the prediction that the majority of A:A homodimers are associated with I&#x003ba;B&#x003b2; for the probable, but not the improbable affinity sets (<xref ref-type="fig" rid="F5">Figure 5D</xref>). Further, the majority of A:50 dimers were predicted to be associated with I&#x003ba;B&#x003b1;, but in some, the primary interaction partner was I&#x003ba;B&#x003b2; (<xref ref-type="fig" rid="F5">Figure 5D</xref>). To test this prediction we prepared cytoplasmic extracts from unstimulated MEFs that contain latent I&#x003ba;B-NF&#x003ba;B complexes. The ionic detergent deoxycholate is known to disrupt I&#x003ba;B-NF&#x003ba;B interactions while leaving the dimer intact and capable of binding DNA (<xref rid="R19" ref-type="bibr">19</xref>), thereby revealing both latent RelA homo- and hetero- dimers (<xref ref-type="fig" rid="F5">Figure 5E</xref>, lane 2). By prior immuno-depleting I&#x003ba;B&#x003b1; or I&#x003ba;B&#x003b2;, we found that I&#x003ba;B&#x003b2; (&#x0003e;50%) is indeed the primary interaction partner for the A:A homodimer (lane 6), whereas I&#x003ba;B&#x003b1; depletion left the A:A homodimer largely intact (lane 4). Additionally, we found that I&#x003ba;B&#x003b1; is the primary interaction partner (&#x0003e;50%) for the A:50 heterodimer (lane 4), although some A:50 is bound to I&#x003ba;B&#x003b2; as well (lane 6). Based on these data, we were able to narrow the probable parameter range by excluding parameter sets that did not satisfy the experimentally determined I&#x003ba;B-NF&#x003ba;B interactions (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>).</p><p id="P19">Finally, we asked whether I&#x003ba;B&#x003b2; is in fact required for A:A homodimer generation. Computational simulations with the probable affinity sets predicted a dramatic decrease (&#x0003c;20% of wild type) in A:A homodimer abundance in I&#x003ba;B&#x003b2; -deficient but not I&#x003ba;B&#x003b1;-deficient cells (<xref ref-type="fig" rid="F5">Figure 5F</xref>). Improbable parameter affinity sets yielded variable amounts of A:A homodimer abundance in the three genotypes. Our experimental analysis supported the probable affinity sets&#x02019; predictions: I&#x003ba;B&#x003b2; -deficient cells showed a dramatic drop (&#x0003c;2% of wild type) in the A:A homodimer abundance as revealed by deoxycholate treatment of cytoplasmic extracts, whereas I&#x003ba;B&#x003b1;-deficiency did not appear to alter the A:A homodimer repertoire (&#x0003e;97% of wild type) (<xref ref-type="fig" rid="F5">Figure 5G</xref>). We then determined which of the parameter sets passed the above three tests. Remarkably, none of the improbable parameters allowed for correct predictions, while two parameter sets from the initially determined probable range did (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>). These three model-directed experimental studies thus support the notion that a high affinity for the A:A homodimer endows I&#x003ba;B&#x003b2; with a stabilizing role in the abundance of the A:A homodimer. Interestingly, two NF&#x003ba;B target genes (<italic>MIP-2</italic> and <italic>TNF&#x003b1;</italic>), whose expression was found to be mediated by RelA:RelA homodimers, showed a marked reduction in I&#x003ba;B&#x003b2; -deficient cells (particularly at late time points), whereas expression of RelA:p50 target genes was not reduced but elevated instead (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 3</xref>).</p></sec><sec id="S6"><title>I&#x003ba;B&#x003b2; counters monomer competition to rescue RelA homodimer</title><p id="P20">Our work thus far has identified two systems properties that control the RelA:RelA abundance: monomer competition, and I&#x003ba;B&#x003b2; -mediated stabilization. These mechanisms have opposing effects on RelA:RelA homodimer abundance, and so we examined their relationship to each other by simulating the effect of I&#x003ba;B&#x003b2; -deficiency in the context of p50-containing or p50-deficient cells. In p50-deficient cells, compensation by p52 is observed but remains incomplete (<xref rid="R7" ref-type="bibr">7</xref>); in our simulations we account for that with a 30-fold reduction in p50 synthesis rates (qualitatively similar results were obtained with a range of synthesis rates) (<xref ref-type="fig" rid="F6">Figure 6A</xref>). We find that loss of I&#x003ba;B&#x003b2; in p50-deficient cells result in lower A:A abundance, though the A:A homodimer remains detectable in contrast to results in p50-containing cells, in which A:A abundance was more I&#x003ba;B&#x003b2; -dependent (<xref ref-type="fig" rid="F5">Figure 5F, G</xref>).</p><p id="P21">To test the validity of this model prediction, we generated p50/I&#x003ba;B&#x003b2; -doubly-deficient MEFs and compared relative abundances of RelA homodimers as determined by EMSA (<xref ref-type="fig" rid="F1">Figure 1C</xref> and <xref ref-type="fig" rid="F6">6B</xref>). We found that in good agreement with the model predictions, I&#x003ba;B&#x003b2; -deficiency results in a lower A:A abundance, but that detectable levels of A:A homodimer remained. Thus both our modeling and experimental results support the notion that I&#x003ba;B&#x003b2; controls A:A abundance, and further suggest that I&#x003ba;B&#x003b2; plays a key role in neutralizing the effect of monomer competition on the abundance of the low affinity A:A homodimer.</p></sec><sec id="S7"><title>I&#x003ba;B&#x003b1; controls the dynamics of both RelA-containing dimers</title><p id="P22">The described mathematical model recapitulates the functions of the Rel-NF&#x003ba;B dimer generation module in generating the latent NF&#x003ba;B dimer repertoire in unstimulated fibroblasts. To study stimulus-induced dynamic regulation of the generation, activation and inactivation of RelA homo- and hetero- dimers, we connected this model with a well-tested model of the I&#x003ba;B-NF&#x003ba;B signaling module (<xref rid="R20" ref-type="bibr">20</xref>) to generate Model 4 (<xref ref-type="fig" rid="F7">Figure 7A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 4A, Supplementary Table 4, Supplementary Table 5, Supplementary Table 6, Supplementary Note 4</xref>).</p><p id="P23">A hallmark of NF&#x003ba;B signaling is negative feedback control mediated by I&#x003ba;B&#x003b1; that ensures post-induction repression of RelA:p50 activity following transient exposure to inflammatory cytokines (<xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R21" ref-type="bibr">21</xref>). To test whether the resulting model recapitulates the signaling dynamics of two NF&#x003ba;B dimers, we simulated TNF-induced signaling. Model simulations showed transient activation of both dimers in wild type cells with relative abundances that are supported by experimental measurements of both dimers. Post-induction repression was mediated by I&#x003ba;B&#x003b1;, as <italic>i&#x003ba;b&#x003b1;<sup>&#x02212;/&#x02212;</sup></italic> MEFs showed sustained activity in both computational (<xref ref-type="fig" rid="F7">Figure 7B</xref>) and experimental studies (<xref ref-type="fig" rid="F7">Figure 7C</xref>), not only of the A:50 heterodimer, but also of the A:A homodimer. The sustained A:A homodimer activity in <italic>i&#x003ba;b&#x003b1;<sup>&#x02212;/&#x02212;</sup></italic> MEFs is not due to an increase of I&#x003ba;B&#x003b2; protein levels (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 4B</xref>), but rather arises from the loss of negative feedback regulation of I&#x003ba;B&#x003b1;. While previous work has demonstrated the critical role of I&#x003ba;B&#x003b1; in the dynamic control of RelA:p50, our simulation and experimental results provide evidence that I&#x003ba;B&#x003b1; plays a role in the dynamic control of RelA:RelA activity as well.</p><p id="P24">We were curious how it could be possible that I&#x003ba;B&#x003b1; is the key dynamic regulator of A:A activity but does not contribute substantially to A:A homodimer generation. We investigated these two roles as a function of the affinity between I&#x003ba;B&#x003b1; and the A:A homodimer. We simulated both the basal abundance of the A:A homodimer and the duration of A:A homodimer activity above the threshold of a 50% of maximum activity (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 4C</xref>) as a function I&#x003ba;B&#x003b1;-A:A homodimer affinities over a thousand-fold range (<xref ref-type="fig" rid="F7">Figure 7D</xref>). We found that lowering the I&#x003ba;B&#x003b1;-A:A affinity would prolong A:A homodimer activity following transient stimulation, but have little impact on A:A abundance; however, increasing the affinity would increase the basal abundance of the A:A homodimer. We thus conclude that the I&#x003ba;B&#x003b1; affinity for the A:A homodimer is tuned to be low enough that I&#x003ba;B&#x003b1; does not function within the Rel-NF&#x003ba;B dimer generation module, but high enough so that it functions within the I&#x003ba;B-NF&#x003ba;B signaling module to control the dynamics of A:A activity.</p></sec></sec><sec sec-type="discussion" id="S8"><title>Discussion</title><p id="P25">The described work reveals a novel and specific function for I&#x003ba;B&#x003b2;. I&#x003ba;Bs are named &#x0201c;inhibitors of NF&#x003ba;B&#x0201d; because they are capable of inhibiting NF&#x003ba;B DNA binding activity in cell free <italic>in vitro</italic> assays (<xref rid="R19" ref-type="bibr">19</xref>), and I&#x003ba;B&#x003b2; was identified in that same manner (<xref rid="R22" ref-type="bibr">22</xref>). However, we show here that <italic>in vivo</italic> I&#x003ba;B&#x003b2; functions primarily as a positive regulator of NF&#x003ba;B dimer generation. Whereas the RelA:p50 dimers can readily form, owing to a high dimerization affinity, RelA:RelA homodimer formation requires the stabilizing influence of I&#x003ba;B&#x003b2;. These distinct functions of I&#x003ba;B&#x003b2; and other I&#x003ba;Bs explain the phenotypes observed in knockout mice.</p><p id="P26">Previous studies of the I&#x003ba;B-NF&#x003ba;B signaling module revealed that negative feedback by I&#x003ba;B&#x003b1;, I&#x003ba;B&#x003b5;, and I&#x003ba;B&#x003b4; shape the dynamics of NF&#x003ba;B activity in response to stimuli (<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R21" ref-type="bibr">21</xref>, <xref rid="R23" ref-type="bibr">23</xref>&#x02013;<xref rid="R25" ref-type="bibr">25</xref>). Indeed prolonged NF&#x003ba;B activity leads to a severe hyper-inflammatory phenotype in I&#x003ba;B&#x003b1;-deficient mice, and to hyper-proliferation in B-cells lacking I&#x003ba;B&#x003b5; (<xref rid="R26" ref-type="bibr">26</xref>) or I&#x003ba;B&#x003b4; (Almaden et al, in press). However, I&#x003ba;B&#x003b2; -deficient mice were recently reported to have hypo-inflammatory responses, reduced expression of TNF, and resistance to endotoxic shock and collagen-induced arthritis (<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R27" ref-type="bibr">27</xref>). We show here that I&#x003ba;B&#x003b2; -deficient fibroblasts lack one member of the NF&#x003ba;B dimer family, namely the homodimer of the potent activator RelA (<xref ref-type="fig" rid="F3">Figure 3</xref>). Similar resultant RelA:RelA and RelA:cRel-deficiency has been observed in <italic>i&#x003ba;b&#x003b2;<sup>&#x02212;/&#x02212;</sup></italic> macrophages (<xref rid="R5" ref-type="bibr">5</xref>).</p><p id="P27">Previously established mathematical models of the I&#x003ba;B-NF&#x003ba;B signaling module are unable to account for this phenotype. These models assume a constant amount of NF&#x003ba;B dimer as a given quantity, and calculate the control of its sub-cellular localization and DNA binding activity as a function of dynamically regulated I&#x003ba;B degradation and re-synthesis. Here, we have constructed a model for the Rel-NF&#x003ba;B dimer generation module and parameterized based on biophysical measurements of recombinant proteins and a series of iterative cycles of prediction and <italic>in vivo</italic> measurements. Our work reveals that I&#x003ba;B&#x003b2; is critical for NF&#x003ba;B RelA:RelA homodimers in MEFs, whose spontaneous generation is challenged not only by poor intrinsic dimer affinities, but also by competition with the high affinity heterodimerization partner p50.</p><p id="P28">A key feature of I&#x003ba;B&#x003b2; function is an unusually high affinity for RelA:RelA homodimers (3.2 pM). As recombinant I&#x003ba;B&#x003b2; is not mono-dispersed in cell free systems, this model-aided interpretation of cellular measurements cannot be tested directly. While sub-nanomolar dissociation constants have previously been reported for other protein-protein interactions (<xref rid="R28" ref-type="bibr">28</xref>), it may be prudent to reconsider the simplifying assumption of the coarse grained model formulation in which I&#x003ba;B&#x003b2; interacts only with the pre-formed dimer. Instead, I&#x003ba;B&#x003b2; might be able to bind monomers sequentially (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 5A</xref>), in which case I&#x003ba;B&#x003b2; may be considered a <italic>bona-fide</italic> chaperone for RelA:RelA homodimer formation. Whereas the single step reaction scheme in the original model is +<italic>A</italic> &#x02194; <italic>A</italic><sub>2</sub> + <italic>B</italic> &#x02194; <italic>A</italic><sub>2</sub><italic>B</italic>, defining dissociation constants as <inline-formula><mml:math id="M1" overflow="scroll"><mml:mi>K</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>A</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:math></inline-formula>, <italic>and</italic><inline-formula><mml:math id="M2" overflow="scroll"><mml:mi>K</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi>B</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>B</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:math></inline-formula>, the two-step reaction scheme would be <italic>A</italic> + <italic>B</italic> &#x02194; <italic>AB</italic> + <italic>A</italic> &#x02194; <italic>A</italic><sub>2</sub><italic>B</italic>, defining dissociation constants <inline-formula><mml:math id="M3" overflow="scroll"><mml:mi>K</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>A</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi>B</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mi>K</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi>A</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:msub><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>B</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:math></inline-formula>, and <inline-formula><mml:math id="M4" overflow="scroll"><mml:mi>K</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mn>4</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>K</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>K</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow><mml:mrow><mml:mi>K</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:math></inline-formula>. Whereas <italic>Kd<sub>1</sub></italic> and <italic>Kd<sub>2</sub></italic> were determined to be 800 nM and 3.2 &#x000d7; 10<sup>&#x02212;3</sup> nM respectively, in the two-step model, <italic>Kd<sub>3</sub></italic> is inversely proportional to <italic>Kd<sub>4</sub></italic> (<xref ref-type="supplementary-material" rid="SD1">Supplementary Figure 5B</xref>). Thus a two-step model would yield interaction constants in the micro- and nano- molar ranges that are more commonly observed within bi-molecular interactions.</p><p id="P29">In addition to I&#x003ba;B&#x003b2; &#x02019;s described role within the Rel-NF&#x003ba;B dimer generation module, a hypo-phosphorylated I&#x003ba;B&#x003b2; has also been shown to have nuclear functions in macrophages in protecting promoter-bound NF&#x003ba;B from I&#x003ba;B&#x003b1;-mediated negative feedback (<xref rid="R29" ref-type="bibr">29</xref>). Resistance to negative feedback may be imparted particularly to those NF&#x003ba;B dimers (e.g. A:A and RelA:cRel) that show high affinity for I&#x003ba;B&#x003b2; (<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R27" ref-type="bibr">27</xref>). As such, both the proposed nuclear function and the here-described chaperone function are a consequence of the high affinity for specific dimers revealed through our iterative experimental and computational study.</p><p id="P30">The parameterization of computational models is a recognized challenge of systems biology. Whereas strategies have been developed to parameterize mathematical synthesis and degradation expressions, as well as those describing enzymatic functions within cells, the interactions between proteins are rarely quantitatively addressed. <italic>Ex vivo</italic>, affinity and kinetic rate constants can be determined for the interaction of recombinant proteins, but the <italic>in vivo</italic> relevance of such constants is limited by the difficulties of producing recombinant full-length proteins with appropriate post-translational modifications. Here we exploited the fact the I&#x003ba;B abundance is a function of its interaction with NF&#x003ba;B (<xref rid="R12" ref-type="bibr">12</xref>) (<xref ref-type="fig" rid="F2">Figure 2B</xref>) and employed computational modeling in order to derive <italic>in vivo</italic> interaction affinities from immunoblot quantifications. Interestingly, it was previously observed that RelA deficiency results in I&#x003ba;B&#x003b2; deficiency (<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R31" ref-type="bibr">31</xref>), and such obligate interactions are not rare (<xref rid="R32" ref-type="bibr">32</xref>, <xref rid="R33" ref-type="bibr">33</xref>), suggesting that our model parameterization strategy may be employed for other biological systems.</p><p id="P31">We described the Rel-NF&#x003ba;B dimer generation module and the I&#x003ba;B-NF&#x003ba;B signaling module as distinct but there are of course numerous interactions. At a minimum, we may consider that I&#x003ba;B&#x003b2;, within the Rel-NF&#x003ba;B dimer generation module, functions as a &#x02018;licensing factor&#x02019; for subsequent dynamic control by I&#x003ba;B&#x003b1;. The distinct functions by these structurally homologous proteins are based on both their specific protein-interaction constants, and on their distinct dynamic degradation and synthesis control. Indeed, the regulatory utility of such &#x02018;hand-off&#x02019; or &#x02018;relay control&#x02019; network motifs, based on kinetic differences between family members, may be a driver of the expansion of protein families.</p></sec><sec sec-type="materials|methods" id="S9"><title>Materials and Methods</title><sec id="S10"><title>Computational modeling</title><p id="P32">Four computational models were constructed for this study. Models 1&#x02013;3 (<xref ref-type="supplementary-material" rid="SD1">Supplementary Notes 1&#x02013;3</xref>) address how NF&#x003ba;B dimers are generated from RelA and p50 NF&#x003ba;B monomers and how interactions with two I&#x003ba;B isoforms may affect the abundance of these dimers; model 4 addresses how nuclear localization of these NF&#x003ba;B dimers is induced and regulated following TNF-induced IKK activation.</p><p id="P33">Model 1 (<xref ref-type="fig" rid="F1">Figure 1A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Note 1</xref>) contains RelA and p50, which form 3 NF&#x003ba;B dimers: RelA:A, RelA:p50, p50:p50. The rate constants for the parameters in these equations are found in <xref ref-type="supplementary-material" rid="SD1">Supplemental Table 1</xref>.</p><p id="P34">Model 2 (<xref ref-type="fig" rid="F3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Note 2</xref>) is based on model 1 above. A generic I&#x003ba;B can complex with RelA:A and RelA:p50. The p50:p50 dimer has not been demonstrated to bind to I&#x003ba;B, so that interaction is excluded from this model.) We assume no degradation of the I&#x003ba;B- NF&#x003ba;B complex or the NF&#x003ba;B dimer from the complex; the dimer may dissociate or I&#x003ba;B may degraded and release the NF&#x003ba;B dimer. The rate constants for the parameters in these equations are found in <xref ref-type="supplementary-material" rid="SD1">Supplemental Table 2</xref>.</p><p id="P35">Model 3 (<xref ref-type="fig" rid="F5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Note 3</xref>) is based on Model 2. I&#x003ba;B&#x003b1;/&#x003b5; and I&#x003ba;B&#x003b2; are the specific I&#x003ba;Bs in the model, which can complex with RelA:A and RelA:p50. For simplicity, I&#x003ba;B&#x003b1; and I&#x003ba;B&#x003b5; are assumed to have the same molecular interaction characteristics and are treated as a single I&#x003ba;B species. The rate constants for the parameters in these equations are found in <xref ref-type="supplementary-material" rid="SD1">Supplemental Table 3</xref>. Parameterization of the model required exploration of the parameter space for I&#x003ba;B-NF&#x003ba;B affinities and determining the likelihood of each set of parameter values (see results <xref ref-type="fig" rid="F4">Figure 4B</xref>). Further parameterization involved additional experimental data (<xref ref-type="fig" rid="F5">Figure 5</xref>) in order to eliminate non-conforming parameter sets (see <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>).</p><p id="P36">Model 4 (<xref ref-type="fig" rid="F7">Figure 7A</xref>, <xref ref-type="supplementary-material" rid="SD1">Supplementary Note 4</xref>) appends previously published I&#x003ba;B-NF&#x003ba;B signaling models (<xref rid="R25" ref-type="bibr">25</xref>, <xref rid="R34" ref-type="bibr">34</xref>) with the reactions that govern NF&#x003ba;B dimer generation and dimer-I&#x003ba;B interactions as described in model 3, but I&#x003ba;B&#x003b1; and I&#x003ba;B&#x003b2; are explicitly enumerated. The complete new model contains 40 species and 110 reactions governed by 65 parameters (<xref ref-type="supplementary-material" rid="SD1">Supplementary Table 4</xref>). I&#x003ba;B-NF&#x003ba;B affinities were determined based on a series of experimental data that had to be satisfied (see <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>); parameterization included basal protein abundance measurements (<xref ref-type="supplementary-material" rid="SD1">Supplemental Table 6</xref>)..</p><p id="P37">The model ODEs were solved numerically using MATLAB version R2013a (The MathWorks, Inc.) with subroutine <italic>ode15s</italic>, a variable order, multi-step solver. The system was allowed to equilibrate from starting conditions to a steady state, defined as showing no concentration changes greater than 1% over a period of 4000 minutes. Stimulus-induced perturbation from the steady state of Model 4 was accomplished by direct modulation of IKK activity via a numerical input curve representing TNF stimulation (adapted from Werner 2008). MATLAB code files are available upon request.</p></sec><sec id="S11"><title>Deriving I&#x003ba;B-NF&#x003ba;B affinities</title><p id="P38">Model 2 was used to calculate the I&#x003ba;B abundances in RelA:p50-deficient and RelA:RelA-deficient cells using NF&#x003ba;B dimerization affinities (determined by 31 sets of <italic>d</italic> parameters for homodimers and 31 sets of heterodimers) and I&#x003ba;B-NF&#x003ba;B interaction affinities (determined by 61 sets of <italic>di</italic> parameters for I&#x003ba;B&#x003b1; and 61 for I&#x003ba;B&#x003b2;). NF&#x003ba;B dimerization affinities were measured with an assumed variance of two-fold, and so each I&#x003ba;B abundance in each cell could be associated with a probability. These were intersected with the experimentally determined distributions of I&#x003ba;B abundances (defined by mean and standard deviation), allowing us to determine the probability (based on available experimental data) that a specific set of the 3,575,881 possible parameter sets is correct. The probabilities for I&#x003ba;B-NF&#x003ba;B interaction affinities are shown in <xref ref-type="fig" rid="F4">Figure 4B</xref>. Specific sets of probable and improbable parameter combinations were further tested in <xref ref-type="fig" rid="F5">Figure 5</xref> against various experimentally determined outcomes to narrow down the most probably parameter sets.</p></sec><sec id="S12"><title>Cell culture</title><p id="P39">Immortalized MEFs were prepared and cultured as previously described (<xref rid="R21" ref-type="bibr">21</xref>, <xref rid="R23" ref-type="bibr">23</xref>). Briefly, cells were grown to confluence in Dulbecco&#x02019;s Modified Eagle&#x02019;s Medium (DMEM) supplemented with 10% bovine calf serum, 1% penicillin-streptomycin, and 1% L-Glutamine. Stimulations were performed using 1ng/mL TNF (Roche). The cell lines used were: wild-type (Hoffmann <italic>et al</italic>, 2002), <italic>i&#x003ba;b&#x003b2;<sup>&#x02212;/&#x02212;</sup></italic> (<xref rid="R23" ref-type="bibr">23</xref>), <italic>i&#x003ba;b&#x003b1;<sup>&#x02212;/&#x02212;</sup>i&#x003ba;b&#x003b5;<sup>&#x02212;/&#x02212;</sup></italic>(<xref rid="R21" ref-type="bibr">21</xref>), <italic>i&#x003ba;b&#x003b1;<sup>&#x02212;/&#x02212;</sup>i&#x003ba;b&#x003b2;<sup>&#x02212;/&#x02212;</sup>i&#x003ba;b&#x003b5;<sup>&#x02212;/&#x02212;</sup></italic>(<xref rid="R12" ref-type="bibr">12</xref>), <italic>rela<sup>&#x02212;/&#x02212;</sup></italic>(<xref rid="R7" ref-type="bibr">7</xref>), <italic>rela<sup>&#x02212;/&#x02212;</sup>crel<sup>&#x02212;/&#x02212;</sup>nfkb1<sup>&#x02212;/&#x02212;</sup></italic>(<xref rid="R12" ref-type="bibr">12</xref>), <italic>nfkb1<sup>&#x02212;/&#x02212;</sup>nfkb2<sup>&#x02212;/&#x02212;</sup></italic>(<xref rid="R7" ref-type="bibr">7</xref>). <italic>crel<sup>&#x02212;/&#x02212;</sup>relb<sup>&#x02212;/&#x02212;</sup>nfkb1<sup>&#x02212;/&#x02212;</sup>nfkb2<sup>&#x02212;/&#x02212;</sup></italic> knockouts were generated from E12.5&#x02013;14.5 embryos and immortalized following the 3T3 protocol.</p></sec><sec id="S13"><title>Biochemistry</title><p id="P40">EMSA (<xref rid="R21" ref-type="bibr">21</xref>), deoxycholate (DOC) + EMSA (<xref rid="R24" ref-type="bibr">24</xref>), EMSA supershift (<xref rid="R35" ref-type="bibr">35</xref>), wild-type + mutant oligo competition EMSA (<xref rid="R7" ref-type="bibr">7</xref>), immunodepletion, RNase Protection Assay (<xref rid="R23" ref-type="bibr">23</xref>), and immunoblotting (<xref rid="R21" ref-type="bibr">21</xref>) were performed as previously described. Briefly, for EMSA, nuclei were collected by hypotonic lysis and resuspended in 30&#x000b5;l NE buffer (250mM Tris pH7.8, 60mM KCl, 1mM EDTA, 1mM DTT, 1mM PMSF) and lysed by 3 freeze-thaw cycles. Nuclear lysates were cleared by 14000g centrifugation and adjusted to 1&#x000b5;g/&#x000b5;l total protein concentration. 2&#x000b5;g of total nuclear protein was incubated at room temperature for 15min. with 0.1pmoles of P32-labelled 30pb double-stranded oligonucleotide containing a consensus &#x003ba;B-site (AGCTTGCTACAA<bold>GGGACTTTCC</bold>GCTGTCTACTTT) in 3&#x000b5;l binding buffer (10mM Tri.Cl pH7.5, 50mM NaCl, 10% glycerol, 1% NP-40, 1mM EDTA, 0.1&#x000b5;g/&#x000b5;l polydIdC). Complexes were resolved on a non-denaturing gel and visualized using a Typhoon Scanner (GE Healthcare Life Sciences). For DOC sensitivity, 2&#x000b5;g of nuclear extract was treated with DOC to a final concentration of 0.8% for 30min and subsequently subjected to EMSA analysis. For supershifts, nuclear extracts were incubated with indicated antibody cocktails for 20 min on ice prior to probe incubation followed by resolution on non-denaturing gel. For wt-mutant competition EMSA, nuclear extracts were incubated with 100-fold molar excess of wt and mutant &#x003ba;B probes and resolved as before. For RNase Protection assay, total RNA was made from confluent serum-starved fibroblasts using Trizol-Reagent (Ambion by Life Technologies). RNase Protection Analysis was performed with 5&#x000b5;g RNA using Riboquant probe set mCK-5 (Pharmingen) according to manufacturers instructions. For whole cell western blots, cells were lysed within six-well plates using SDS&#x02013;PAGE sample buffer, resolved on acrylamide gels, transferred to PVDF membranes and probed with specified antibodies.</p><p id="P41">I&#x003ba;B&#x003b1; (sc-371, 1:5,000), I&#x003ba;B&#x003b2; (sc-946, 1:5,000 for immunoblot and sc-969, 1:20, for immunodepletion), RelA (sc-372, 1:5,000) antibodies were provided by Santa Cruz Biotechnology. p50 N-terminal antisera (1:10,000) was a generous gift from Nancy Rice.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>1</label><media xlink:href="NIHMS676392-supplement-1.pdf" orientation="portrait" xlink:type="simple" id="d37e1266" position="anchor"/></supplementary-material></sec></body><back><ack id="S14"><title>Acknowledgments</title><p id="P42">We thank E. Komives and G. Ghosh (UCSD) for insightful discussions concerning I&#x003ba;B:NF&#x003ba;B interactions and NF&#x003ba;B dimer association kinetics, and J.A Vargas for critical reading and editing. <bold>Funding</bold>: This study was supported by National Institutes of Health grant R01AI083463 (AH), P50 GM085763 (AH) and P01 GM071862 (AH and GG). R.T. was supported by National Science Foundation Graduate Fellowship. J.D.K. was supported by an American Heart Association Predoctoral Fellowship.</p></ack><fn-group><fn id="FN4" fn-type="con"><p id="P43"><bold>Author contributions</bold>: Computational modeling work was performed by RT and JDK, and experimental work by CL, KN, SB, RT, DV, KN and JDK, with supervision from AH and GG. RT and AH wrote the manuscript, based on an early draft by JDK. AH planned and oversaw the project.</p></fn><fn id="FN5" fn-type="conflict"><p id="P44"><bold>Competing interests</bold>: The authors declare no conflicts of interest.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Natoli</surname><given-names>G</given-names></name><name><surname>Ghosh</surname><given-names>G</given-names></name></person-group><article-title>Transcriptional regulation via the NF-kappaB signaling module</article-title><source>Oncogene</source><year>2006</year><volume>25</volume><fpage>6706</fpage><lpage>6716</lpage><pub-id pub-id-type="pmid">17072323</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Hayden</surname><given-names>MS</given-names></name></person-group><article-title>New regulators of NF-kappaB in inflammation</article-title><source>Nat. Rev. Immunol</source><year>2008</year><volume>8</volume><fpage>837</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">18927578</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savinova</surname><given-names>OV</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Ghosh</surname><given-names>G</given-names></name></person-group><article-title>The Nfkb1 and Nfkb2 proteins p105 and p100 function as the core of high-molecular-weight heterogeneous complexes</article-title><source>Mol. Cell</source><year>2009</year><volume>34</volume><fpage>591</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">19524538</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname><given-names>S</given-names></name><name><surname>Behar</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name></person-group><article-title>Lessons from mathematically modeling the NF-&#x003ba;B pathway</article-title><source>Immunol. Rev</source><year>2012</year><volume>246</volume><fpage>221</fpage><lpage>238</lpage><pub-id pub-id-type="pmid">22435558</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>P</given-names></name><etal/></person-group><article-title>I&#x003ba;B&#x003b2; acts to inhibit and activate gene expression during the inflammatory response</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>1115</fpage><lpage>1119</lpage><pub-id pub-id-type="pmid">20740013</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liou</surname><given-names>HC</given-names></name><name><surname>Sha</surname><given-names>WC</given-names></name><name><surname>Scott</surname><given-names>ML</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation</article-title><source>Mol Cell Biol</source><year>1994</year><volume>14</volume><fpage>5349</fpage><lpage>5359</lpage><pub-id pub-id-type="pmid">8035813</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Leung</surname><given-names>TH</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities</article-title><source>EMBO J</source><year>2003</year><volume>22</volume><fpage>5530</fpage><lpage>5539</lpage><pub-id pub-id-type="pmid">14532125</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>TH</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>453</fpage><lpage>464</lpage><pub-id pub-id-type="pmid">15315758</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fusco</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Stabilization of RelB Requires Multidomain Interactions with p100/p52</article-title><source>Journal of Biological Chemistry</source><year>2008</year><volume>283</volume><fpage>12324</fpage><lpage>12332</lpage><pub-id pub-id-type="pmid">18321863</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maine</surname><given-names>GN</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Komarck</surname><given-names>CM</given-names></name><name><surname>Burstein</surname><given-names>E</given-names></name></person-group><article-title>COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><fpage>436</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">17183367</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huxford</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>DB</given-names></name><name><surname>Malek</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>G</given-names></name></person-group><article-title>The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation</article-title><source>Cell</source><year>1998</year><volume>95</volume><fpage>759</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">9865694</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Dea</surname><given-names>EL</given-names></name><etal/></person-group><article-title>A homeostatic model of I[kappa]B metabolism to control constitutive NF-[kappa]B activity</article-title><source>Mol Syst Biol</source><year>2007</year><volume>3</volume></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>ML</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Liou</surname><given-names>HC</given-names></name><name><surname>Nolan</surname><given-names>GP</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms</article-title><source>Genes Dev</source><year>1993</year><volume>7</volume><fpage>1266</fpage><lpage>1276</lpage><pub-id pub-id-type="pmid">8319912</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pando</surname><given-names>MP</given-names></name><name><surname>Verma</surname><given-names>IM</given-names></name></person-group><article-title>Signal-dependent and -independent Degradation of Free and NF-&#x003ba;B-bound I&#x003ba;B&#x003b1;</article-title><source>J. Biol. Chem</source><year>2000</year><volume>275</volume><fpage>21278</fpage><lpage>21286</lpage><pub-id pub-id-type="pmid">10801847</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>H</given-names></name><etal/></person-group><article-title>Chronic Inflammation and Susceptibility to Bacterial Infections in Mice Lacking the Polypeptide (p)105 Precursor (NF-&#x003ba;B1) but Expressing p50</article-title><source>J Exp Med</source><year>1998</year><volume>187</volume><fpage>985</fpage><lpage>996</lpage><pub-id pub-id-type="pmid">9529315</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname><given-names>CB</given-names></name><name><surname>Sengchanthalangsy</surname><given-names>LL</given-names></name><name><surname>Huxford</surname><given-names>T</given-names></name><name><surname>Ghosh</surname><given-names>G</given-names></name></person-group><article-title>Mechanism of I&#x003ba;B&#x003b1; Binding to NF-&#x003ba;B Dimers</article-title><source>J. Biol. Chem</source><year>2000</year><volume>275</volume><fpage>29840</fpage><lpage>29846</lpage><pub-id pub-id-type="pmid">10882738</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergqvist</surname><given-names>S</given-names></name><etal/></person-group><article-title>Kinetic enhancement of NF-&#x003ba;B&#x000b7;DNA dissociation by I&#x003ba;B&#x003b1;</article-title><source>Proceedings of the National Academy of Sciences</source><year>2009</year><volume>106</volume><fpage>19328</fpage><lpage>19333</lpage></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gapuzan</surname><given-names>M-ER</given-names></name><name><surname>Schmah</surname><given-names>O</given-names></name><name><surname>Pollock</surname><given-names>AD</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Gilmore</surname><given-names>TD</given-names></name></person-group><article-title>Immortalized fibroblasts from NF-&#x003ba;B RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor &#x003b1; after transformation by v-Ras</article-title><source>Oncogene</source><year>2005</year><volume>24</volume><fpage>6574</fpage><lpage>6583</lpage><pub-id pub-id-type="pmid">16027734</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baeuerle</surname><given-names>PA</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>I kappa B: a specific inhibitor of the NF-kappa B transcription factor</article-title><source>Science</source><year>1988</year><volume>242</volume><fpage>540</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">3140380</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Encoding NF-&#x003ba;B temporal control in response to TNF: distinct roles for the negative regulators I&#x003ba;B&#x003b1; and A20</article-title><source>Genes &#x00026; Development</source><year>2008</year><volume>22</volume><fpage>2093</fpage><lpage>2101</lpage><pub-id pub-id-type="pmid">18676814</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Levchenko</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>ML</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>The Ikappa B-NF-kappa B Signaling Module: Temporal Control and Selective Gene Activation</article-title><source>Science</source><year>2002</year><volume>298</volume><fpage>1241</fpage><lpage>1245</lpage><pub-id pub-id-type="pmid">12424381</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zabel</surname><given-names>U</given-names></name><name><surname>Baeuerle</surname><given-names>PA</given-names></name></person-group><article-title>Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA</article-title><source>Cell</source><year>1990</year><volume>61</volume><fpage>255</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">2184941</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearns</surname><given-names>JD</given-names></name><name><surname>Basak</surname><given-names>S</given-names></name><name><surname>Werner</surname><given-names>SL</given-names></name><name><surname>Huang</surname><given-names>CS</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name></person-group><article-title>I&#x003ba;B&#x003b5; provides negative feedback to control NF-&#x003ba;B oscillations, signaling dynamics, and inflammatory gene expression</article-title><source>The Journal of Cell Biology</source><year>2006</year><volume>173</volume><fpage>659</fpage><lpage>664</lpage><pub-id pub-id-type="pmid">16735576</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname><given-names>S</given-names></name><etal/></person-group><article-title>A Fourth I&#x003ba;B Protein within the NF-&#x003ba;B Signaling Module</article-title><source>Cell</source><year>2007</year><volume>128</volume><fpage>369</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">17254973</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>VF-S</given-names></name><etal/></person-group><article-title>Kinetic control of negative feedback regulators of NF-&#x003ba;B/RelA determines their pathogen- and cytokine-receptor signaling specificity</article-title><source>Proceedings of the National Academy of Sciences</source><year>2009</year><volume>106</volume><fpage>9619</fpage><lpage>9624</lpage></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alves</surname><given-names>BN</given-names></name><etal/></person-group><article-title>I&#x003ba;B{varepsilon} Is a Key Regulator of B Cell Expansion by Providing Negative Feedback on cRel and RelA in a Stimulus-Specific Manner</article-title><source>J. Immunol</source><year>2014</year><volume>192</volume><fpage>3121</fpage><lpage>3132</lpage><pub-id pub-id-type="pmid">24591377</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheibel</surname><given-names>M</given-names></name><etal/></person-group><article-title>I&#x003ba;B&#x003b2; is an essential co-activator for LPS-induced IL-1&#x003b2; transcription in vivo</article-title><source>J Exp Med</source><year>2010</year><volume>207</volume><fpage>2621</fpage><lpage>2630</lpage><pub-id pub-id-type="pmid">20975042</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salimi-Moosavi</surname><given-names>H</given-names></name><name><surname>Rathanaswami</surname><given-names>P</given-names></name><name><surname>Rajendran</surname><given-names>S</given-names></name><name><surname>Toupikov</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>J</given-names></name></person-group><article-title>Rapid affinity measurement of protein&#x02013;protein interactions in a microfluidic platform</article-title><source>Analytical Biochemistry</source><year>2012</year><volume>426</volume><fpage>134</fpage><lpage>141</lpage><pub-id pub-id-type="pmid">22542978</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suyang</surname><given-names>H</given-names></name><name><surname>Phillips</surname><given-names>R</given-names></name><name><surname>Douglas</surname><given-names>I</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name></person-group><article-title>Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B</article-title><source>Mol. Cell. Biol</source><year>1996</year><volume>16</volume><fpage>5444</fpage><lpage>5449</lpage><pub-id pub-id-type="pmid">8816457</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertlein</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ladner</surname><given-names>KJ</given-names></name><name><surname>Bakkar</surname><given-names>N</given-names></name><name><surname>Guttridge</surname><given-names>DC</given-names></name></person-group><article-title>RelA/p65 Regulation of I&#x003ba;B&#x003b2;</article-title><source>Mol. Cell. Biol</source><year>2005</year><volume>25</volume><fpage>4956</fpage><lpage>4968</lpage><pub-id pub-id-type="pmid">15923614</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valovka</surname><given-names>T</given-names></name><name><surname>Hottiger</surname><given-names>MO</given-names></name></person-group><article-title>p65 controls NF-&#x003ba;B activity by regulating cellular localization of I&#x003ba;B&#x003b2;</article-title><source>Biochemical Journal</source><year>2011</year><volume>434</volume><fpage>253</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">21158742</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Thornton</surname><given-names>JM</given-names></name></person-group><article-title>Principles of protein-protein interactions</article-title><source>PNAS</source><year>1996</year><volume>93</volume><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">8552589</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mintseris</surname><given-names>J</given-names></name><name><surname>Weng</surname><given-names>Z</given-names></name></person-group><article-title>Structure, function, and evolution of transient and obligate protein&#x02013;protein interactions</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>10930</fpage><lpage>10935</lpage><pub-id pub-id-type="pmid">16043700</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>VF-S</given-names></name><etal/></person-group><article-title>Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-&#x003ba;B pathways</article-title><source>Nat Immunol</source><year>2012</year><volume>13</volume><fpage>1162</fpage><lpage>1170</lpage><pub-id pub-id-type="pmid">23086447</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname><given-names>S</given-names></name><name><surname>Shih</surname><given-names>VF-S</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name></person-group><article-title>Generation and Activation of Multiple Dimeric Transcription Factors Within the NF-&#x003ba;B Signaling System</article-title><source>Mol. Cell. Biol</source><year>2008</year><volume>28</volume><fpage>3139</fpage><lpage>3150</lpage><pub-id pub-id-type="pmid">18299388</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Monomer competition reduces the abundance of the RelA homodimer</title><p id="P45">A. A schematic of a simple model depicting the dimerization of NF&#x003ba;B RelA and p50 polypeptides. <italic>m<sub>1</sub></italic> and <italic>m<sub>2</sub></italic> are synthesis rate constants, <italic>m<sub>&#x02212;1</sub></italic> and <italic>m<sub>&#x02212;2</sub></italic> are degradation rate constants. <italic>d<sub>1</sub>, d<sub>2</sub></italic>, and <italic>d<sub>3</sub></italic> are dimer association rate constants, while <italic>d<sub>&#x02212;1</sub>, d<sub>&#x02212;2</sub>,</italic> and <italic>d<sub>&#x02212;3</sub></italic> are dimer dissociation rate constants. <italic>dd<sub>&#x02212;1</sub></italic>, <italic>dd<sub>&#x02212;2</sub></italic>, and <italic>dd<sub>&#x02212;3</sub></italic> are dimer degradation rate constants.</p><p id="P46">B. Heat maps of protein abundances of A:A and A:50 dimers computationally simulated as a function of the dimer affinities (Kd). These were generated by the model schematized in (A).</p><p id="P47">C. Electrophoretic mobility shift assays (EMSA) with nuclear extracts prepared from TNF-stimulated (30 min) wild type mouse embryonic fibroblasts (MEFs). The identity of the indicated DNA-protein complexes were confirmed using competition (comp.) with a 100-fold excess of unlabeled double stranded oligonucleotide that either contains the wild type (wt) or mutant (mt) &#x003ba;B site sequence. The RelA and p50 antibody (&#x003b1;&#x02013;RelA and &#x003b1;-p50) are used in shift-ablation studies to confirm that the identity of the A:A-DNA and A:50-DNA complexes.</p><p id="P48">D. EMSA with nuclear extracts prepared from TNF-stimulated (30 min) wild type and <italic>nfkb1<sup>&#x02212;/&#x02212;</sup></italic> MEFs.</p><p id="P49">E. Bar graph comparison of the abundances of A:A NF&#x003ba;B dimers wild type and <italic>nfkb1<sup>&#x02212;/&#x02212;</sup></italic> relative to the wild type A:50 bands (100%) from panel (D).</p></caption><graphic xlink:href="nihms676392f1"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Biophysical kinetic model underestimates the abundance of the RelA homodimer</title><p id="P50">A. Summary table of dimer affinities as measured by analytical ultracentrifugation (AUC) and quantitative gel-filtration analysis of purified recombinant proteins (<xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 1B&#x02013;E</xref>). The A:A homodimer affinity is lower than those of p50-containing dimers.</p><p id="P51">B. The bar graph is a quantitation from <xref ref-type="fig" rid="F1">Figure 1</xref> showing a comparison of model predicted (blue) and experimentally measured (red) relative abundances of A:A and A:50 dimers.</p></caption><graphic xlink:href="nihms676392f2"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Differential interaction affinities for I&#x003ba;B and NF&#x003ba;B family members</title><p id="P52">A. A model schematic of the Rel-NF&#x003ba;B dimer generation module. It depicts the dimerization of RelA and p50 NF&#x003ba;B polypeptides as in <xref ref-type="fig" rid="F1">Figure 1A</xref>, with the addition of a prototypical inhibitor of NF&#x003ba;B (I&#x003ba;B). <italic>m<sub>1</sub></italic> and <italic>m<sub>2</sub></italic> are RelA and p50 synthesis rate constants, <italic>m<sub>&#x02212;1</sub></italic> and <italic>m<sub>&#x02212;2</sub></italic> are RelA and p50 degradation rate constants. <italic>d<sub>1</sub>, d<sub>2</sub></italic>, and <italic>d<sub>3</sub></italic> are dimer association rate constants, while <italic>d<sub>&#x02212;1</sub>, d<sub>&#x02212;2</sub>,</italic> and <italic>d<sub>&#x02212;3</sub></italic> are A:A, A:p50, and p50:p50 dimer dissociation rate constants. <italic>dd<sub>&#x02212;1</sub></italic>, <italic>dd<sub>&#x02212;2</sub></italic>, and <italic>dd<sub>&#x02212;3</sub></italic> are A:A, A:p50, and p50:p50 dimer degradation rate constants. <italic>i<sub>1</sub></italic> is the I&#x003ba;B synthesis rate constant, <italic>i<sub>&#x02212;1</sub></italic> is the I&#x003ba;B degradation rate constant. <italic>di<sub>1</sub></italic> and di<sub><italic>2</italic></sub> are the I&#x003ba;B-NF&#x003ba;B association rate constants. <italic>di<sub>&#x02212;1</sub></italic> and <italic>di<sub>&#x02212;2</sub></italic> are the I&#x003ba;B-NF&#x003ba;B dissociation rate constants. <italic>did<sub>1</sub></italic> and <italic>did<sub>2</sub></italic> are the I&#x003ba;B-NF&#x003ba;B degradation rate constants of I&#x003ba;B to release NF&#x003ba;B.</p><p id="P53">B. Immunoblot (left panel) of whole cell extracts of wild type MEFs and MEFs deficient in canonical NF&#x003ba;B genes (RelA, cRel, and p50) using antibodies against the indicated proteins (I&#x003ba;B&#x003b1;, I&#x003ba;B&#x003b2;, and I&#x003ba;B&#x003b5;). RNAse protection assay (RPA, right panel) of previous extracts to measure transcript levels of the indicated genes (I&#x003ba;B&#x003b1;, I&#x003ba;B&#x003b2;, I&#x003ba;B&#x003b5;, and L32). Immunoblot and RPA data are representative of more than three independent experiments that consistently show a deep reduction I&#x003ba;B protein levels without a corresponding reduction in transcript levels.</p><p id="P54">C. Immunoblot of indicated I&#x003ba;Bs in indicated NF&#x003ba;B dimer compound knockout MEFs as compared to wild type MEFs, with the indicated NF&#x003ba;B dimers below. The blot is a representative of three independent experiments that consistently showed that presence of RelA is required and sufficient for the detection of I&#x003ba;B&#x003b2; protein. Quantitation of this data is shown as bar graphs in <xref ref-type="fig" rid="F4">Figure 4A</xref>.</p></caption><graphic xlink:href="nihms676392f3"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Deriving probable I&#x003ba;B-NF&#x003ba;B interaction affinities from experimental data</title><p id="P55">A. Surface plots of indicated I&#x003ba;B abundances (&#x02212;&#x003b1; or &#x02212;&#x003b2;) in cells deficient for the indicated NF&#x003ba;B dimer (RelA:p50 heterodimer-deficient, top; RelA:RelA homodimer-deficient, bottom) over the indicated ranges of I&#x003ba;B-NF&#x003ba;B affinities, as predicted by the model schematized in <xref ref-type="fig" rid="F3">Figure 3A</xref>. Middle, bar graphs of the experimentally I&#x003ba;B abundances in the indicated NF&#x003ba;B dimer-deficient cells relative to WT. (A representative data figure is shown in <xref ref-type="fig" rid="F3">Figure 3C</xref>.) Experimentally determined abundances constrained the range of allowable I&#x003ba;B-NF&#x003ba;B affinities in the surface plots, indicated by shadows on the xy-plane.</p><p id="P56">B. Heat maps of probable I&#x003ba;B-NF&#x003ba;B affinities. Probabilities (indicated in the color scale) were calculated using the distribution experimental measurements, defined by mean and standard deviation (<xref ref-type="fig" rid="F2">Figure 2A</xref>, <xref ref-type="fig" rid="F3">Figure 3C</xref>, Figure 4A); they describe the relative likelihood that an indicate parameter set if correct based on available experimental data. The most probable I&#x003ba;B-NF&#x003ba;B affinities are in red, while the least probable affinities are in dark blue. Selected probable and improbable parameter values are indicated (white letters and numbers, listed in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>), and were used for model predictions in <xref ref-type="fig" rid="F5">Figure 5</xref>.</p></caption><graphic xlink:href="nihms676392f4"/></fig><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><title>Iterative testing and refinement of the I&#x003ba;B&#x003b2; -RelA homodimer preference model</title><p id="P57">A. A model schematic of the Rel-NF&#x003ba;B dimer generation module, as in <xref ref-type="fig" rid="F3">Figure 3A</xref> but with two I&#x003ba;Bs, I&#x003ba;B&#x003b1; and I&#x003ba;B&#x003b2;, necessitating <italic>i<sub>1</sub></italic> and <italic>i<sub>2</sub></italic> synthesis rate constants, <italic>i<sub>&#x02212;1</sub></italic> and <italic>i<sub>&#x02212;2</sub></italic> degradation rate constants, <italic>di<sub>1</sub>,di<sub>2</sub></italic>, <italic>di<sub>3</sub></italic>, and <italic>di<sub>4</sub></italic> I&#x003ba;B-NF&#x003ba;B association rate constants. <italic>di<sub>&#x02212;1</sub></italic>, <italic>di<sub>&#x02212;2</sub>, di<sub>&#x02212;3</sub>,</italic> and <italic>di<sub>&#x02212;4</sub></italic> I&#x003ba;B-NF&#x003ba;B dissociation rate constants, and <italic>did<sub>1</sub></italic>, <italic>did<sub>2</sub>, did<sub>3</sub>,</italic> and <italic>did<sub>4</sub></italic> I&#x003ba;B-NF&#x003ba;B degradation rate constants of I&#x003ba;B to release NF&#x003ba;B.</p><p id="P58">B. Computational prediction of RelA protein abundance in A:50-deficient cells (relative to wild type cells), using probable (red) and improbable (blue) affinities shown in <xref ref-type="fig" rid="F4">Figure 4B</xref> and listed in <xref ref-type="supplementary-material" rid="SD1">Supplementary Table 5</xref>.</p><p id="P59">C. Immunoblot against RelA of whole cell extracts from RelA-deficient, wild type, and RelA-only MEFs. The right panel shows the quantitation of three independent experiments. These consistently showed values of &#x0003e; 0.5.</p><p id="P60">D. Computational predictions of the abundances of NF&#x003ba;B dimers RelA:RelA (left) and RelA:p50 (right) bound to either I&#x003ba;B&#x003b1; or I&#x003ba;B&#x003b2; as indicated. These calculations used probable (red) and improbable affinities (blue) as in panel B.</p><p id="P61">E. Electrophoretic mobility shift assay of deoxycholate (DOC)-treated cytoplasmic extracts (which results in the separation of NF&#x003ba;B dimers from I&#x003ba;Bs) to quantitate I&#x003ba;B-bound NF&#x003ba;B dimer abundance. Prior immunodepletion of the extracts with antibodies against I&#x003ba;B&#x003b1; or I&#x003ba;B&#x003b2; allows quantitation of NF&#x003ba;B bound to the remaining I&#x003ba;B isoform. Data shown is representative of three independent experiments, and the right panel shows the corresponding quantitation.</p><p id="P62">F. Computational predictions of the basal abundances of the RelA:RelA homodimer in wild type, I&#x003ba;B&#x003b2; -deficient, and I&#x003ba;B&#x003b1;-deficient MEFs using probable (red) and improbable (blue) affinities as in panel B.</p><p id="P63">G. Electrophoretic mobility shift assays (left panel) of DOC-treated cytoplasmic extracts of wild type, I&#x003ba;B&#x003b2; -deficient, and I&#x003ba;B&#x003b1;/&#x003b5;-deficient MEFs. Shown is a representative result of three independent experiments, and the right panel shows the corresponding quantitation.</p></caption><graphic xlink:href="nihms676392f5"/></fig><fig id="F6" orientation="portrait" position="float"><label>Figure 6</label><caption><title>I&#x003ba;B&#x003b2; is important in RelA homodimer formation</title><p id="P64">A. Bar graph depicting the simulation results of NF&#x003ba;B dimer abundances in wild type, I&#x003ba;B&#x003b2; -deficient, p50-deficient, and I&#x003ba;B&#x003b2; /p50 doubly deficient MEFs. Compensation by p52 in p50-deficient cells was simulated by allowing for synthesis of a p50-like molecular species.</p><p id="P65">B. Electrophoretic shift mobility assay of nuclear extracts prepared from p50- deficient and p50/I&#x003ba;B&#x003b2; -deficient MEFs treated with TNF at 10 and 30 minutes. In the absence of p50-mediated monomer competition, the RelA:RelA homodimer is highly abundant, even in the absence of I&#x003ba;B&#x003b2;. Data shown is representative of three independent experiments.</p></caption><graphic xlink:href="nihms676392f6"/></fig><fig id="F7" orientation="portrait" position="float"><label>Figure 7</label><caption><title>While I&#x003ba;B&#x003b2; regulates NF&#x003ba;B/RelA homodimer generation, I&#x003ba;B&#x003b1; regulates its signaling</title><p id="P66">A. A schematic showing the linking of the Rel-NF&#x003ba;B dimer generation module and the I&#x003ba;B-NF&#x003ba;B signaling module (<xref rid="R20" ref-type="bibr">20</xref>) to simulate stimulus-induced activation of multiple NF&#x003ba;B dimers. I&#x003ba;B&#x003b1;, I&#x003ba;B&#x003b2;, and I&#x003ba;B&#x003b5; interact with A:A and A:50 dimers as described in <xref ref-type="fig" rid="F5">Figure 5A</xref>. A detailed model schematic is shown in <xref ref-type="supplementary-material" rid="SD1">Supplemental Figure 5A</xref>.</p><p id="P67">B. Computational time course simulations of TNF-stimulated nuclear DNA binding activity of the indicated NF&#x003ba;B dimers A:50 (left, solid lines) and A:A (right, dashed lines) in wild type (blue) and I&#x003ba;B&#x003b1;-deficient (red) MEFs. Both dimer activities exhibit post-induction repression mediated by I&#x003ba;B&#x003b1;.</p><p id="P68">C. Electrophoretic mobility shift assays (top panels) of nuclear extracts of wild-type and I&#x003ba;B&#x003b1;-deficient MEFs prepared from TNF-stimulated cells at 30, 60 and 90 minutes. Quantitation (bottom panels) of the A:50 (solid lines) A:A and A:50 (dashed lines) NF&#x003ba;B dimers show prolonged activation in I&#x003ba;B&#x003b1; deficient (right, red) as compared to wild-type (left, blue) MEFs. Shown is a representative of at least three independent experiments.</p><p id="P69">D. Computational simulations of A:A abundance (green) and duration of TNF-induced A:A activity (purple) as a function of the interaction affinity between I&#x003ba;B&#x003b1; and the A:A. These simulations were performed with the integrated model described in (A), and they show that a lower Kd would allow I&#x003ba;B&#x003b1; to contribute to A:A generation, while a higher Kd would reduce I&#x003ba;B&#x003b1;&#x02019;s ability to terminate TNF-induced A:A activity.</p></caption><graphic xlink:href="nihms676392f7"/></fig></floats-group></article>